Eli Lilly is paying up to $630m for a Phase I metabolic-associated steatohepatitis (MASH) candidate from South Korea-based biotech OliX Pharmaceuticals, diversifying its pipeline for the disease ...

Revenue forecasts to 2035 for Liver Fibrosis & NASH/MASH Drugs Market 2025 to 2035, with forecasts for Type and Indication, each forecast at a global and regional level - discover the industry's ...

LE MARS - The Northwest Iowa Genealogical Society (NWIGS) will hold its monthly meeting on Saturday, April 19, at 1:30 p.m., in the fourth-floor study hall of the Plymouth County ...